EU/mL
A concentration-based reporting unit. Its interpretation depends on the sample preparation and reporting basis.
Understand bacterial endotoxin testing, assay suitability and the reporting details that make a result interpretable.

Bacterial endotoxin testing assesses endotoxin using a suitable assay and defined reporting basis. It is separate from microbial growth testing and does not assess every possible pyrogen. Read the result with its units, dilution, reporting limit, suitability information and applicable specification; a bare “pass” label leaves important questions unanswered.
| Approach | What to confirm |
|---|---|
| LAL-based methods | Selected gel-clot, chromogenic or turbidimetric approach, procedure and result format. |
| Recombinant-reagent methods | The specific reagent system, method and suitability for the material. |
| Any selected assay | The reporting basis, interference assessment, limits and criterion used for interpretation. |
FDA’s March 2026 update accommodates a broader scope of recombinant reagents and highlights suitability for intended use. Its discussion aligns with USP <86>. This is a reason to confirm the actual assay, rather than describe LAL as the only possible approach.
A concentration-based reporting unit. Its interpretation depends on the sample preparation and reporting basis.
A different basis that needs the relevant mass or unit definition. Do not compare numbers across units without the necessary information.
A result below a reporting limit is not a statement that the sample contains absolute zero endotoxin.
Do not apply a generic endotoxin limit to every sample. Document the specification and its basis with the appropriate responsible party before interpreting compliance.
Formulation ingredients and sample preparation can affect an assay response. Ask how inhibition or enhancement is evaluated and how the chosen dilution and reporting limit support the intended conclusion.
| Report field | Why it matters |
|---|---|
| Sample and lot | Connects the result to the submitted material. |
| Assay and method | Identifies the analytical approach. |
| Units and dilution basis | Makes the measured number interpretable. |
| Suitability / interference information | Supports interpretation in this sample matrix. |
| Result and reporting limit | Distinguishes a measured value from a below-limit statement. |
| Specification and qualifications | Explains the criterion and any limitations. |
Share the exact claimed identity, formulation, physical form, labeled amount and lot identifier. Include existing documentation if available.
Confirm methods, sample requirements, pricing, timing, report outputs and submission instructions before sending material.
Check the sample identifier, method, units, reporting limits and any agreed specification. Ask about unexplained or unresolved findings.
PeptideValidation.com sells laboratory testing services for client-supplied samples. Share the material description and your testing question so method suitability and submission requirements can be confirmed.
The assessments address different questions. A microbial growth result does not establish the bacterial endotoxin result.
No. Current FDA guidance also discusses recombinant-reagent approaches. Confirm the assay selected and its suitability for your material.
No. Interpret that wording against the assay’s reporting limit, dilution, units and suitability in the submitted matrix.
No. Conversion requires the relevant concentration or mass basis. Ask the laboratory to explain the reported basis before comparing results.
No. It is one analytical result under a defined scope, not a complete safety or suitability assessment.